bPiDI

MedChem Express

bPiDI [525596-64-9]

14

Research Use Only

99.65

C22H34I2N2

580.33

bPiDI is a novel selective alpha6beta2 nicotinic receptor antagonist. bPiDI inhibits nicotine-evoked striatal dopamine (DA) release through an interaction with alpha6beta2-containing nAChRs[1].

CC1=CC=C[N+](CCCCCCCCCC[N+]2=CC(C)=CC=C2)=C1.[I-].[I-]

2°C to 8°C

12131703